Neonatal Loss Secondary to Third Trimester Chemotherapy for Maternal Breast Cancer

Authors

  • Özgür Özyüncü Hacettepe University Faculty of Medicine, Department of Obstetrics and Gynecology, Ankara
  • Işın Üreyen Hacettepe University Faculty of Medicine, Department of Obstetrics and Gynecology, Ankara
  • Sadettin Kılıçkap Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara
  • Yusuf Alper Kılıç Hacettepe University Faculty of Medicine, Department of General Surgery, Ankara
  • Sezcan Mümüşoğlu Hacettepe University Faculty of Medicine, Department of Obstetrics and Gynecology, Ankara
  • Sinan Beksaç Hacettepe University Faculty of Medicine, Department of Obstetrics and Gynecology, Ankara

Keywords:

Pregnancy, Breast cancer, Chemotherapy

Abstract

Breast cancer is the most common cancer among women with a lifetime risk of 11%. Pregnancy-associated breast cancer is defined as cancer diagnosed during pregnancy or up to 1 year post partum. Surgery is the definitive treatment for pregnancy-associated breast cancer. For node-positive patients or node-negative patients with a tumor greater than 1 cm, a 4 to 6 month course of chemotherapy is the standard of care. Provided that chemotherapy is not used in the first trimester, it appears to be relatively safe.
A forty-two year old pregnant woman in the third trimester presented with an advanced breast cancer. Since she had an advanced stage cancer and since she was in the third trimester, she was decided to be treated with chemotherapy. After three weeks, an emergent cesarean section was performed because the fetus was in acute distress. On the 20th day, the baby died because of cardiopulmonary arrest.
The cause of the death was concluded as perinatal hypoxia secondary to chemotherapy.
Even though chemotherapy is shown to be safe during the second and third trimester in many clinical trials, each case should be handled separately since the assumption of safety may differ in each case. These pregnants should be observed closer

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2010-04-10

How to Cite

1.
Özyüncü Özgür, Üreyen I, Kılıçkap S, Kılıç YA, Mümüşoğlu S, Beksaç S. Neonatal Loss Secondary to Third Trimester Chemotherapy for Maternal Breast Cancer. Gynecol Obstet Reprod Med [Internet]. 2010Apr.10 [cited 2022Aug.17];16(1):56-8. Available from: https://gorm.com.tr/index.php/GORM/article/view/338

Issue

Section

Case Reports

Most read articles by the same author(s)

1 2 3 4 5 > >>